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Abstract
Background: Early human heart and brain development simultaneously occur
during embryogenesis. Notably, in human newborns, congenital heart defects
strongly associate with neurodevelopmental abnormalities, suggesting a common
gene or complex underlying both cardiogenesis and neurogenesis. However, due to
lack of in vivo studies, the molecular mechanisms that govern both early human
heart and brain development remain elusive.
Results: Here, we report ARID1A, a DNA-binding subunit of the SWI/SNF epigenetic
complex, controls both neurogenesis and cardiogenesis from human embryonic
stem cells (hESCs) through distinct mechanisms. Knockout-of-ARID1A (ARID1A−/−)
leads to spontaneous differentiation of neural cells together with globally enhanced
expression of neurogenic genes in undifferentiated hESCs. Additionally, when
compared with WT hESCs, cardiac differentiation from ARID1A −/− hESCs is
prominently suppressed, whereas neural differentiation is significantly promoted.
Whole genome-wide scRNA-seq, ATAC-seq, and ChIP-seq analyses reveal that
ARID1A is required to open chromatin accessibility on promoters of essential
cardiogenic genes, and temporally associated with key cardiogenic transcriptional
factors T and MEF2C during early cardiac development. However, during early neural
development, transcription of most essential neurogenic genes is dependent on
ARID1A, which can interact with a known neural restrictive silencer factor REST/NRSF.
Conclusions: We uncover the opposite roles by ARID1A to govern both early cardiac and
neural development from pluripotent stem cells. Global chromatin accessibility on
cardiogenic genes is dependent on ARID1A, whereas transcriptional activity of neurogenic
genes is under control by ARID1A, possibly through ARID1A-REST/NRSF interaction.
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Introduction
Human cardiogenesis and neurogenesis occur contemporaneously, and both have a
similar process of morphogenesis including germ layer segregation, progenitor cell dif-
ferentiation, cell fate specification, cell migration, left/right patterning, and dorsal/ven-
tral patterning [1–3]. Heart and brain development also share complex cellular
interactions. For example, neural crest cells (NCCs), which are capable of differenti-
ation into peripheral neurons and glia, are also able to migrate from the pharyngeal
arch arteries (PAA) and heart outflow tract (OFT) to the primitive heart and give rise
to smooth muscle, connective tissue, and great arteries of the heart [4]. Notably, new-
borns with congenital heart defects exhibited a high frequency of neurodevelopmental
deficits [4, 5]. Previous studies revealed that epigenetic regulatory mechanisms, such as
DNA methylation [6], histone modifications [7], and chromatin remodeling [8–11],
played essential roles in heart and neural development in mammals. However, the mo-
lecular mechanisms driving both cardiogenesis and neurogenesis in human embryos re-
main unclear. A better understanding of these mechanisms is critical for studying
etiology of human congenital cardiac and neural defects.
The evolutionarily conserved ATP-dependent SWI/SNF complex is one of the largest
chromatin-remodeling complexes, consisting of as many as 15 subunits, including
SMARCA2 (also known as BRM) or SMARCA4 (also known as BRG1) as the ATPase
catalytic subunit [12]. Several BRG1-associated factors (BAFs), such as ARID1A
(Baf250a), have DNA binding capacity and assemble with either BRM or BRG1 to form
a functional chromatin-remodeling complex [13]. BAFs also associate with other co-
factors to determine the identity of a given SWI/SNF chromatin-remodeling complex
and which consequently dictate where that complex will act [14]. As previously re-
ported, ARID1A (Baf250a) binds promoter regions of transcription factors in a
sequence-specific manner to drive SWI/SNF recruitment [15]. Loss of Ariad1a in mice
results in embryonic lethality and developmental arrest at around day E6.5, showing
lack of primitive streak or mesoderm formation [16]. A single amino acid mutation
(Arid1aV1068G/V1068G) impaired Arid1a-DNA interactions [15] and resulted in neural
defects including cranioschisis and neural tube defects, as well as cardiac defects in-
cluding defective trabeculation, hypoplastic myocardial walls, and ventricular septal
malformation. Additionally, homozygous loss-of-ARID1a in mouse neural crest cells re-
sulted in embryonic lethality at around E15, with prominent heart defects that included
incomplete formation of the cardiac outflow tract septum and defective posterior
pharyngeal arteries [17]. ARID subunits are among the most frequently mutated
SWI/SNF subunits found in human disease [17]. Mutations in 4 different SWI/SNF
subunits including ARID1A/B were identified in three congenital syndromes that
include both neural and cardiac defects: Coffin-Siris syndrome (CSS), Nicolaides-
Baraitser syndrome (NCBRS), and ARID1B-related intellectual disability (ID) syn-
drome [13, 18–21]. Patients with these syndromes show severe intellectual deficits
as well as cardiac defects such as atrial/ventricular septal defects, patent ductus
arteriosus (PDA), mitral and pulmonary atresia, aortic stenosis, and single right
ventricle. These data indicate that abnormal ARID1A activity can lead to defective
formation of both the heart and brain in humans. However, the molecular mecha-
nisms by which ARID1A controls human cardiogenesis and neurogenesis still re-
main elusive.
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In this study, we investigate the roles of ARID1A in early human cardiac and neural
development by using an in vitro human embryonic stem cell (hESC) model [22–25].
Expression of ARID1A is upregulated during early cardiac differentiation from hESCs.
Surprisingly, knockout-of-ARID1A in hESCs (ARID1A−/−) led to spontaneous neural
differentiation even under pluripotent stem cell culture conditions. Additionally, under
conditions of targeted cardiac differentiation, ARID1A−/− hESCs gave rise to robustly
increased numbers of neural cells, including neural stem cells and neurons, whereas
cardiac differentiation was significantly suppressed when compared with WT hESCs.
scRNA-seq revealed cellular and transcriptional heterogeneities between ARID1A−/−
and WT hESCs. ATAC-seq (Assay for Transposase-Accessible Chromatin using se-
quencing) demonstrated changes in chromatin accessibility on ARID1A-occupied car-
diogenic and neurogenic genes in ARID1A−/− vs. WT hESCs, while ChIP-seq revealed
differences in genome-wide ARID1A occupancy on promoters of essential cardiogenic
and neurogenic genes. When integrated, these unbiased genome-wide studies revealed
loss-of-ARID1A globally reduced chromatin accessibility and expression of essential
cardiogenic genes, but did not uniformly affect chromatin accessibility on neurogenic
genes. Furthermore, we performed Co-IP to show ARID1A interacted with key cardiac
transcriptional factors T and MEF2C at the mesoderm and cardiac progenitor cell for-
mation stages during human cardiogenesis. We identified that ARID1A recruited the
transcriptional repressor element-1 (RE1) silencing transcription factor/neuron-restrict-
ive silencer factor (REST/NRSF) to co-occupy the promoters of neurogenic genes, but
not cardiogenic genes, thereby suppressing transcription of neurogenic genes. Collect-
ively, our findings reveal distinct and novel mechanisms by which ARID1A drives early
human cardiogenesis and neurogenesis, primarily via chromatin remodeling and gene
transcription regulation, respectively.
Results
Whole mRNA-seq predicts ARID1A in cardiac development from hESCs
Previously, we established a cardiovascular differentiation protocol from human embry-
onic stem cells (hESCs) by adding different combinations of growth factors including
BMP4/bFGF/Activin A and VEGF/DKK1 at different stages [26]. Temporal analyses
using whole mRNA sequencing analyses revealed that this cytokine treatment paradigm
results in the progressive appearance of multipotential cardiovascular progenitors
(MCPs), cardiomyocytes (CMs), smooth muscle cells (SMs), and endothelial cells (ECs)
(Fig. 1a) [26, 27]. Gene Ontology (GO) biological process analysis by Metacore found
the upregulated genes were significantly enriched into cardiac development (Fig. 1b)
and chromatin organization events (Fig. 1c), suggesting a critical role for chromatin
organization/remodeling mechanism(s) during early human cardiac development. Of
interest, the upregulated genes included subunits of the SWI/SNF chromatin-
remodeling complex, BAF250A (ARID1A) and BAF53A, which may regulate expression
of GATA4 (a key cardiogenic transcription factor, Fig. 1d). This suggests a potential
role of SWI/SNF chromatin-remodeling complex in early human heart development.
Next, we profiled the expression pattern of essential SWI/SNF components in above
five cell lineages by whole mRNA-seq (Fig. 1e). We found that expression level of
ARID1A, a subunit of SWI/SNF complex with DNA binding capacity, significantly
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increased during hESC differentiation to cardiac progenitors (Fig. 1e). qRT-PCR ana-
lysis confirmed the increased expression of ARID1A during cardiac differentiation of
hESCs (Fig. 1f). Cardiac troponin T (CTNT), which is a CM-specific marker gene, also
showed increased expression during cardiac differentiation (Fig. 1f). Tissue-wide gene
expression profiling demonstrated ARID1A in human adult heart tissue (Add-
itional file 1: Fig. S1a). Given that loss-of-Arid1a in mouse leads to severe
Fig. 1 Loss-of-ARID1A induces spontaneous differentiation of hESCs. a Scheme for whole transcriptome
sequencing of cardiovascular cell lineages derived from human embryonic stem cells (hESCs). b, c Gene
Ontology (GO) biological process analysis of upregulated genes (MCP vs. hESCs) showing enriched heart
development events (b) and epigenetic regulation events (c) during human cardiac development. d
Interaction network analysis of SWI/SNF complex subunits and other cardiogenic genes by Metacore
software. e Gene expression profiles of SWI/SNF subunits in different cardiovascular lineages by whole
transcriptome sequencing. f Expression dynamics of ARID1A and key cardiac genes during cardiac
differentiation of H9 hESCs. RNAs were collected every 2 days from day 0 to day 10 of cardiac
differentiation. g Strategy for completely knocking out human ARID1A in H9 hESCs using CRISPR/Cas9. h
PCR screening for ARID1A−/− hESC clones. i ARID1A mRNA expression detected by qRT-PCR. All bars are
shown as mean ± SD. n = 3, *p < 0.05 (an unpaired two-tailed t test with Welch’s correction). j ARID1A
protein expression levels detected by Western blot. k WT and ARID1A−/− hESCs were cultured in mTesR
medium. ARID1A−/− hESCs displayed small clusters of differentiated cells (red arrow heads and white arrows
indicate two different cell types). All functional analysis and gene interaction network analyses were done
by Metacore (Clarivate Analytics)
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developmental defects in both the heart and neural tube [15], we decided to delete
ARID1A expression in H9 hESCs by using dual gRNA-mediated CRISPR/Cas-9 tech-
nology (Fig. 1g, Additional file 1: S1b). Two ARID1A−/− hESC clones (#132 and #180)
were identified by PCR (Fig. 1h, Additional file 1: S1c). ARID1A mRNA (Fig. 1i) and
protein (Fig. 1j) levels were undetectable in ARID1A−/− clones when compared with
WT hESCs. Large ARID1A−/− hESC colonies displayed the same morphologies as WT
hESCs. However, small cell clusters between large ARID1A−/− colonies exhibited
morphology of differentiated cell types (Fig. 1k, Additional file 1: S1d). Those differenti-
ated cell types were not observed in WT hESCs, indicating loss-of-ARID1A may induce
sporadic differentiation of hESCs.
Single-cell RNA sequencing (scRNA-seq) reveals loss-of-ARID1A induces spontaneous
neural differentiation
To determine the identity of differentiated ARID1A−/− hESCs, single-cell RNA sequen-
cing (scRNA-seq) was performed (Fig. 2a). ARID1A mRNA was not detected in
ARID1A−/− hESCs, confirming global ARID1A deficiency (Fig. 2b). Interestingly, ex-
pressions of neural stem cell markers (ZIC1, PAX6, SOX1) and neuron markers
(MAP2, FABP7) were all significantly increased in ARID1A−/− compared with WT
hESCs (p < 2.4E−13, Fig. 2c). Moreover, the percentage of cells positively expressing
ZIC1, PAX6, SOX1, MAP2, and FABP7 were significantly higher in ARID1A−/− hESCs
than those in WT hESCs (p < 1.1E−14, Fig. 2d). In order to further compare the cellular
heterogeneities, scRNA-seq data from both WT and ARID1A−/− hESCs were integrated
and then interrogated with Seurat (an R toolkit for single-cell genomics [28]), to per-
form dimension reduction and cell clustering. In total, 11 clusters were identified, as vi-
sualized by the t-distributed stochastic neighbor embedding (t-SNE) (Fig. 2e) [28, 29].
This revealed high heterogeneities of hESCs under pluripotency culture conditions. All
clusters contained similar percentages of WT and ARID1A−/− hESCs, except cluster 10.
Particularly, over 90% cells in cluster 10 were from ARID1A−/− hESCs (Fig. 2f). Cluster
10 had non-detectable level of ARID1A, but expressed neural stem cell markers ZIC1
and SOX1, and neuron markers MAP2 and FABP7, higher than any other clusters
(Fig. 2g). In addition, neural-associated markers, such as PRTG, CDH6, and PTN, were
highly expressed in cluster 10 (Additional file 1: Fig. S2a). Gene Ontology (GO)
(Fig. 2h), process network, and signaling pathway (Additional file 1: Fig. S2b) analyses
found that the upregulated genes (Additional file 2: Table S1) in cluster 10 (ARID1A−/−
vs. WT) were significantly enriched in neural development events, such as nervous sys-
tem development, neurogenesis, and brain and head development. The feature plots
showed that cells positively expressing neuroectoderm/neural stem cell markers (ZIC1,
PAX6, SOX1) and neuron markers (MAP2, FABP7, PRTG, CDH6, and PTN) were
highly enriched in cluster 10 and globally distributed in other clusters of ARID1A−/−
hESCs (red plots, Fig. 2i, Additional file 1: Fig. S2c). Loss-of-ARID1A resulted in de-
creased expression of OCT4 but did not affect the expression levels of other pluripo-
tency markers (Additional file 1: Fig. S2d). Interestingly, endoderm (Additional file 1:
Fig. S2e), mesoderm, and cardiac marker genes were repressed in ARID1A1/1/ hESCs
(Additional file 1: Figs. S2f-h). Finally, flow cytometry, qRT-PCR, and immunostaining
were performed to verify results from scRNA-seq. Increased percentages of PAX6+,
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Fig. 2 scRNA-seq reveals loss-of-ARID1A induces spontaneous neural differentiation in hESCs. a Undifferentiated WT
and ARID1A−/− hESCs were collected for single-cell RNA sequencing (scRNA-seq). b ARID1A expression in WT and
ARID1A−/− hESCs detected by scRNA-seq. *p<2.4E−13 (Wilcoxon’s test). c Expression levels of neural stem cell markers
(ZIC1, PAX6, SOX1) and neuron markers (MAP2, FABP7) in WT and ARID1A−/− hESCs. *p<2.4E−13 (Wilcoxon’s test). d
Percentage of cells expressing ARID1A, neural stem cell markers (ZIC1, PAX6, SOX1), and neuron markers (MAP2,
FABP7) in WT and ARID1A−/− hESCs. *p< 1.1 E−14 (Fisher’s exact test). e Integrative analysis of scRNA-seq datasets
from WT and ARID1A−/− hESCs. Cell clusters were visualized with t-distributed stochastic neighbor embedding (t-SNE).
f Ratios of WT and ARID1A−/− hESCs in each cluster from integrative scRNA-seq data. g Violin plots of scRNA-seq data
showing expression levels of ARID1A, neural stem cell markers (ZIC1, SOX1), and neuron markers (MAP2, FABP7) in
each cluster. h GO biological process analysis for upregulated genes (ARID1A−/− vs. WT) in cluster 10 by Metacore
software. i Feature plots of scRNA-seq data showing the distribution of cells positively expressing ARID1A, neural stem
cell markers (ZIC1, PAX6, SOX1), and neuron markers (MAP2, FABP7) in all clusters. Red circle indicates the cluster 10
containing neural stem cells and neurons solely derived from in ARID1A−/− hESCs. j, k Flow cytometry data showing
the percentage of PAX6+ (j) and MAP2+ (k) cells in WT and ARID1A−/− hESCs. All bars are shown as mean± SD. n=3,
*p<0.05 (KO vs. WT, an unpaired two-tailed t test with Welch’s correction). l Expression levels of neural-associated
markers analyzed by qRT-PCR. All bars are shown as mean± SD. n=3, *p<0.05 (KO vs. WT, an unpaired two-tailed t
test with Welch’s correction).m Immunomicroscopy to detect neural stem cell markers (PAX6, SOX1) and neuron
marker (MAP2) in WT and ARID1A−/− hESCs. Scale bar, 100μm
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MAP2+, and TUJ1+ (Fig. 2j, k, Additional file 1: Fig. S3a-c) cells were detected in
ARID1A−/− vs. WT hESCs by antibody staining followed with flow cytometry. Expres-
sion levels of neural-associated markers, such as PAX6, SOX1, MAP2, ZIC1, and
FABP7, were significantly upregulated in ARID1A−/− hESCs than those in WT (Fig. 2l,
Additional file 1: Fig. S3d). PAX6+, SOX1+, MAP2+ (Fig. 2m), and TUJ1+ (Additional
file 1: Fig. S3e) cells were detected by fluorescent immunostaining in ARID1A−/−
hESCs, but not in WT hESCs. Collectively, these results demonstrate that loss-of-
ARID1A in hESCs increases transcription of neural genes and induces spontaneous
neural differentiation (Fig. 2i, Additional file 1: Fig. S3f), indicating ARID1A plays an
important role in controlling neurogenesis from hESCs.
ARID1A oppositely controls cardiac and neural development from hESCs
We then asked whether loss-of-ARID1A could affect cardiac and neural differentiation
from hESCs. A monolayer differentiation method [30] was utilized to induce cardiac
differentiation from WT and ARID1A−/− hESCs (Fig. 3a) for 10 days (T10), followed
with scRNA-seq analyses to identify cellular and transcriptional heterogeneities.
scRNA-seq revealed no ARID1A expression in ARID1A−/− hESCs post-cardiac differen-
tiation (Additional file 1: Fig. S4a). By conducting Gene Ontology (GO) (Fig. 3b) and
process network (Additional file 1: Fig. S4b) analyses of all differentially expressed
genes in ARID1A−/− vs. WT cultures (Additional file 2: Table S1), we found that upreg-
ulated genes were significantly enriched for neural commitment events such as nervous
system development, neurogenesis, and neural differentiation signaling pathway,
whereas the downregulated genes were significantly enriched for cardiac commitment
events, including circulatory system development, heart development, cardiac develop-
ment, and cardiac myogenesis signaling pathways. For example, loss-of-ARID1A led to
increased expression of essential neural marker genes (NR2F1, OTX2, PAX6, SOX1,
SOX2, ZIC1, and MAP2) (Fig. 3c) and reduced expression of cardiac marker genes
(HAND1, GATA4, ISL1, NKX2-5, TNNT2, MYH6, and MYH7) (Fig. 3d) at day 10 of
differentiation. Next, we quantified the percentages of single cells which positively
expressed neural and cardiac markers. Ratios of SOX1+, SOX2+, PAX6+, NR2F1+,
OTX2+, and MAP2+ cells were higher in ARID1A−/− cells than in WT cells (p < 3.13E
−163, Fig. 3e). In contrast, ratios of cells expressing cardiac markers, such as HAND1/
2, TBX5, GATA4/5/6, ISL1, NKX2-5, MYH6/7, TNNT2, TNNI3, and TNNC1, were
significantly lower in differentiated ARID1A−/− than in WT hESCs (p < 1.4E−114,
Fig. 3f). scRNA-seq data from WT and ARID1A−/− cells were integrated to generate 12
clusters, which were then interrogated with t-SNE analyses (Fig. 3g, Additional file 1:
Fig. S4c) [28, 29]. Next, the ratios of ARID1A−/− and WT cells in each cell cluster were
analyzed (Fig. 3h). Approximately 90% of cells in clusters 0, 6, 7, and 10 and 60% of
cells in cluster 4 were derived from WT hESCs, whereas about 80% of cells in clusters
1, 2, 3, and 8 and 60% of cells in cluster 5 were derived from ARID1A−/− hESCs. Cells
expressing CM-specific marker genes, such as MYH6, TNNT2 (Fig. 3i), NKX2-5,
GATA4/6, TBX5, MEF2C, MYH7, TNNI3, and TNNC1 (Additional file 1: Fig. S4d),
were enriched in clusters 0, 4, and 6. Neural stem cell/neuroepithelial cell marker
genes, such as ZIC1 (Fig. 3i), NR2F1, NR6A1, PAX6, SOX2/11, and ZIC2 (Additional
file 1: Fig. S4e), were highly expressed in cells of clusters 1, 2, and 3. Additionally, cells
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expressing neuron marker genes MAP2 (Fig. 3i), RBFOX3, SYP, and DCX (Additional
file 1: Fig. S4e) were enriched in clusters 5 and 8. Average gene expression in each cell
cluster (ARID1A−/− vs. WT, Additional file 1: Figs. S4f-k) was consistent with the re-
sults of violin plots. We conducted GO biological process and signaling pathway
Fig. 3 scRNA-seq reveals loss-of-ARID1A represses cardiac but promotes neural differentiation from hESCs. a A
chemically defined cardiac differentiation protocol to induce cardiomyocyte differentiation from hESCs,
followed with scRNAseq. b GO biological process analysis of upregulated and downregulated genes (KO vs. WT
differentiated cells) by Metacore software. c, d Violin plots showing expression of neural-associated markers (c)
and cardiac-associated markers (d) in WT and ARID1A−/− derived cells. *p < 8.32E−100 (Wilcoxon’s test). e, f
Comparison of percentages of WT and ARID1A−/− differentiated cells which positively express neural-associated
markers (e) and cardiac-associated markers (f). *p < 3.13E−163 (Fisher’s exact test) (e), *p < 1.4E−114 (Fisher’s
exact test) (f). g Integrative analysis of scRNA-seq datasets of differentiated WT and ARID1A−/− hESCs. Cell
clusters were visualized with t-distributed stochastic neighbor embedding (t-SNE). h Integrative analysis
showing the ratios of WT and ARID1A−/− cells in each cluster of differentiated cells. i Violin plots showing
expressions of cardiac- and neural-associated markers in all clusters. j, k Feature plots showing the expressions
and distributions of cells positively expressing neural-associated markers (j) and cardiac-associated markers (k)
in the integrated view. l Defined cell types in the separated WT (left) and ARID1A−/− (right) cell clusters. WT
(left) clusters contain most cardiomyocytes, and ARID1A−/− (right) clusters contain most neural cells, indicating
loss-of-ARID1A represses cardiac differentiation and promotes neural differentiation
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analyses of upregulated genes in each cluster. Cardiac/neural development events and
pathways were separately enriched into clusters (Additional file 1: Fig. S5). Feature plots
from integrative analysis further distinguished distribution patterning of cells, which
expressed signature neural and cardiac genes, across all clusters (Fig. 3j, k). Overall,
scRNA-seq analysis found knockout-of-ARID1A predominantly enhanced differenti-
ation of neural cells including neural stem cell, neuroepithelial cell, and mature neuron
from hESCs, whereas differentiation of cardiac cells including cardiomyocyte, endothe-
lial cell, and fibroblast was significantly suppressed (Fig. 3l). Given that cardiomyocyte,
endothelial cell, and fibroblast originate from mesodermal cells, these results imply that
loss-of-ARID1A could repress expression of genes controlling mesoderm formation.
WT and ARID1A−/− hESC-derived cells were collected after 10 days of cardiac differen-
tiation for FACS, qRT-PCR, and immunostaining assessments (Fig. 3a). By performing
FACS analysis, we found over 50% CTNT+ CMs from WT hESCs, whereas less than 20%
CTNT+ CMs from ARID1A−/− hESCs (Fig. 4a, b). Differential CM content in the cultures
was also apparent by grossly monitoring contractile activity (Additional file 3: contractile
activity videos of differentiated WT and ARID1A KO hESCs). However, over 30% of cells
in cultures of ARID1A−/− hESCs subjected to cardiac-directed differentiation were SOX1+
and TUJ1+as compared to less than 3% in cultures of WT hESCs (Fig. 4c, d). qRT-PCR
analysis found loss-of-ARID1A significantly repressed cardiac (Fig. 4e) but prominently
increased neural marker gene expression after differentiation (Fig. 4f). Immunomicro-
scopy detected a large number of CTNT+ CMs (Fig. 4g, h) and undetectable numbers of
TUJ1+, MAP2+, SOX1
+, and SOX2+ neural cells (Fig. 4g–j) derived from WT hESCs. In
contrast, cells derived from ARID1A−/− hESCs gave opposite results (Fig. 4g–j). Next, a
neural-specific differentiation protocol was performed to test whether loss-of-ARID1A
can specifically affect neural commitment (Additional file 1: Fig. S6a). We found
ARID1A−/− hESCs gave rise to significantly increased percentages of PAX6+ and SOX1+
cells than WT hESCs by FACS analysis (Additional file 1: Figs. S6b-c) and immunostain-
ing (Additional file 1: Figs. S6d-e). Expression levels of neural markers, such as PAX6,
SOX1, and NEUROD1, increased after neural differentiation of ARID1A−/− hESCs com-
pared with WT hESCs (Additional file 1: Fig. S6f). Enhanced neural differentiation was
observed in ARID1A−/− hESCs under both neural and cardiac differentiation conditions,
indicating a primary role of ARID1A in governing neural lineage specification from
hESCs. To determine the relationship between the level of ARID1A expression and
lineage commitment from hESCs, a single gRNA targeting the transcriptional start site of
ARID1A was used in combination with CRISPR/Cas9 (Additional file 1: Fig. S6g) to knock
down ARID1A expression to 60% of that in WT hESCs (Additional file 1: Fig. S6h). After
10 days of cardiac differentiation, we found ARID1Aknockdown hESCs gave rise to half of
CTNT+ CMs derived from WT hESCs (Additional file 1: Fig. S6i). Additional experiments
using shRNA-mediated knockdown of ARID1A (Additional file 1: Fig. S6j) confirmed that
downregulation of ARID1A suppressed CM differentiation (Additional file 1: Fig. S6k).
However, no spontaneously differentiated neural cells were found in ARID1Aknockdown
hESCs maintained in pluripotent culture conditions (Additional file 1: Fig. S6l). Together,
these results demonstrate that cardiac differentiation efficiency from hESCs is dependent
on the dose of ARID1A, whereas spontaneous neural differentiation is blocked by the
presence of ARID1A, implying different mechanisms by which ARID1A controls human
cardiogenesis and neurogenesis.
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ATAC-seq reveals global alterations of chromatin remodeling in ARID1A−/− hESCs
Given that SWI/SNF complex remodels chromatin to facilitate transcription of target
genes, we performed ATAC-seq to investigate the impact of ARID1A on chromatin ac-
cessibility during cardiogenesis. hESCs at the day 4 (T4) of cardiac differentiation were
collected for ATAC-seq (Fig. 5a). Global changes of chromatin accessibility, including
increased (Fig. 5b), no change (Fig. 5g), and reduced (Fig. 5k), in ARID1A−/− vs. WT
hESCs were detected (Additional file 4: Table S2). GO analysis identified genes
Fig. 4 Characterization of WT and ARID1A−/− hESC-derived cells. a, b Flow cytometry quantification of the ratios
of CTNT+ CMs derived from WT and ARID1A−/− cells after 10 days cardiac differentiation. All bars are shown as
mean ± SD. n= 3, *p< 0.05 (an unpaired two-tailed t test). c, d Detecting ratios of SOX1+ (c) and TUJ1+ (d) cells in
WT and ARID1A−/− hESC-derived cells by immunostaining. All bars are shown as mean ± SD. n= 3, *p< 0.05 (an
unpaired two-tailed t test). e, f Comparing the expression levels of cardiac markers (e) and neural markers (f) in WT
and ARID1A−/− hESC-derived cells by qRT-PCR. All bars are shown as mean ± SD. n= 3, *p< 0.05 (KO vs. WT for
each gene, an unpaired two-tailed t test). g, h Immunostaining of neuron markers TUJ1 (g) and MAP2 (h) and
cardiomyocyte marker CTNT (g, h) in WT and ARID1A−/− hESC-derived cells after 10 days cardiac differentiation.
Nuclei were labeled by DAPI. Scale bar, 100 μm. i, j Immunostaining of neural stem cell markers SOX1 (i) and SOX2
(j) in WT and ARID1A−/− hESC-derived cells. Nuclei were labeled by DAPI. Scale bar, 100 μm
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Fig. 5 Loss-of-ARID1A leads to changes of chromatin accessibility. a Assay for Transposase-Accessible Chromatin with
high-throughput sequencing (ATAC-seq) was performed after 4 days differentiation of WT and ARID1A−/− hESCs. b
Heatmap and pileup of ATAC-seq signal for genes with increased chromatin accessibility (KO vs. WT). c, d GO
biological process (c) and signaling pathway enrichment (d) analysis of genes with increased chromatin accessibility
(KO vs. WT). The analysis of GO biological process and signaling pathways was performed by Metacore software. e
Genome views of neurogenic genes with increased chromatin accessibility (KO vs. WT) close to transcription start site
(TSS). Arrows showed the transcriptional direction. f qRT-PCR detection of neurogenic gene expression profiles during
cardiac differentiation of hESCs. g Heatmap and pileup of ATAC-seq signals for genes without significant changes on
chromatin accessibility (KO vs. WT). h Signaling pathways enriched in genes with no-changed chromatin accessibility
(KO vs. WT). The analysis of signaling pathways was performed by Metacore software. i Genome views of neurogenic
genes without significant changes on chromatin accessibility (KO vs. WT). j qRT-PCR detection of neurogenic gene
expression profiles during cardiac differentiation of hESCs. k Heatmap and pileup of ATAC-seq signals for genes with
reduced chromatin accessibilities (KO vs. WT). l GO biological process analysis of genes with reduced chromatin
accessibilities (KO vs. WT). The analysis of GO biological process was performed by Metacore software.m List of
essential cardiogenic and cardiac functional genes showing decreased chromatin accessibility in KO cells (KO vs. WT).
n Genome views of some important cardiogenic genes with decreased chromatin accessibility in KO cells compared
to WT. Arrows showed the transcriptional direction. o qRT-PCR detection of cardiogenic gene expression profiles
during cardiac differentiation of hESCs. All bars in RT-qPCR data are shown as mean± SD. n=3, *p<0.05 (KO vs. WT,
an unpaired two-tailed t test with Welch’s correction)
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associated with differential chromatin accessibility changes have distinct biological
functions. Genes with increased (Fig. 5b) or no change (Fig. 5g) of chromatin accessibil-
ity (ARID1A−/− vs. WT) were implicated in neural commitment events such as nervous
system development and neurogenesis (Fig. 5c, d, h, Additional file 1: Fig. S7a). As
shown by ATAC-seq (Fig. 5e) and qRT-PCR (Fig. 5f) analyses, loss-of-ARID1A in-
creased both chromatin accessibility and expression levels of neurogenic genes, such as
ZIC1, LHX5, and FABP7. However, chromatin accessibility on other neurogenic genes,
such as PAX6, SOX1, and FOXG1 (Fig. 5i), exhibited no obvious changes (ARID1A−/−
vs. WT), albeit their significantly increased expression levels (Fig. 5j). These results sug-
gest that transcriptional activities, rather than chromatin accessibility, of critical neuro-
genic genes were dependent on ARID1A. Notably, genes with reduced chromatin
accessibility (ARID1A−/− vs. WT) (Fig. 5k) were mainly enriched in cardiac commit-
ment events, such as circulatory, heart, and cardiovascular system development (Fig. 5l,
Additional file 1: Fig. S7b). These genes included early mesoderm transcriptional fac-
tors T [31–37]; cardiac transcription factors GATA4, ISL1, TBX3, DES, NKX2.5,
TBX5, and TBX18; and sarcomeric genes CTNT and MYH7 (Fig. 5m, n). Additionally,
during cardiac differentiation, expression levels of these cardiogenic genes were all sig-
nificantly decreased in ARID1A−/− cells compared with WT cells (Fig. 5o). Loss-of-
ARID1A did not affect the expression of endoderm marker genes, such as SOX17 and
FOXA2 (Additional file 1: Fig. S7c). Altogether, these results indicate that loss-of-
ARID1A globally reduces chromatin accessibility on essential cardiogenic genes, but
not on neurogenic genes, whereas transcription of essential neurogenic genes is
dependent on ARID1A.
ChIP-seq reveals genome-wide ARID1A occupancy on promoters of essential cardiogenic
and neurogenic genes
Given the DNA binding capacity of ARID1A [15], chromatin immunoprecipitation
assay with sequencing (ChIP-seq) was next carried out to define genome-wide ARID1A
occupancy in hESCs (Fig. 6a). Approximately 61% of ARID1A binding sites located on
regions within 10 kb from transcriptional start sites (TSS), 5′UTR, and gene bodies
(Fig. 6b). Interestingly, GO analyses revealed that genes with ARID1A occupancies
close to TSS (Fig. 6c, Additional file 5: Table S3) were enriched in both neural and car-
diac commitment, such as nervous system development, neurogenesis (Fig. 6d), and
cardiac development/muscle contraction (Fig. 6e). For example, the gene encoding a
transcriptional factor for early mesodermal commitment, EOMES, and genes encoding
key cardiac transcriptional factors, HAND2, GATA4, GATA5, ISL1, and TBX3, were
all occupied by ARID1A on their promoter regions (Fig. 6f, g), which were confirmed
by ChIP-qPCR (Fig. 6h). Both ChIP-seq and ChIP-qPCR also identified ARID1A-
occupied neurogenic genes, such as PAX6, SOX1, FOXG1, and ZIC1 (Fig. 6i–k). Im-
portantly, by comparing the ATAC-seq (Fig. 5m) and ARID1A ChIP-seq data (Fig. 6g),
we found all ARID1A-occupied cardiogenic genes exhibited decreased chromatin acces-
sibility during cardiac commitment from ARID1A−/− vs. WT hESCs, indicating that
chromatin accessibility of cardiogenic genes was dependent on ARID1A. Although
ARID1A occupied promoters of many neurogenic genes (Fig. 6j), most of them, except
several genes including ZIC1, LHX5, and FABP7 (Fig. 5e), did not exhibit significant
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alternations of chromatin accessibility under ARID1A deficiency. This suggests that
ARID1A globally occupies neurogenic gene promoters to suppress transcription via a
non-chromatin-remodeling mechanism. It also implies the existence of ARID1A-
recruited co-factor(s) to repress neurogenic gene transcription.
Fig. 6 ChIP-seq reveals genome-wide ARID1A occupancies on promoters of cardiogenic and neurogenic genes. a
Chromatin immunoprecipitation (ChIP) assays with sequencing (ChIP-Seq) was performed in WT H9 hESCs. b
Distribution of ARID1A ChIP-seq-enriched peaks across human genome. c Relative enrichment levels of ARID1A on
transcription start site (TSS) of coding genes in hESCs. Heatmaps were ranked by ARID1A enrichment. d GO biological
process analysis of genes enriched by ARID1A ChIP-seq. The analysis of GO biological process was performed by
Metacore software. e Process network analysis of genes enriched by ARID1A ChIP-seq. The analysis of process
networks was performed by Metacore software. f Example genome views of ARID1A occupancies on mesodermal TF
EOMES, cardiac TFs HAND2, GATA4, GATA5, ISL1, and TBX3. g List of essential cardiogenic and cardiac functional
genes occupied by ARID1A. h ChIP-qPCR validation of cardiogenic gene promoters occupied by ARID1A. i Example
genome views of ARID1A occupancies on neurogenic genes. j List of essential neurogenic and neural marker genes
occupied by ARID1A. k ChIP-qPCR validation of neurogenic gene promoters occupied by ARID1A. All bars in ChIP-
QPCR data are shown as mean± SD. n=3, *p<0.05 (anti-ARID1A vs. IgG, an unpaired two-tailed t test)
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ARID1A associates with different transcriptional factors
In order to define co-factors that interact with ARID1A, we predicted potential co-TFs
based on their motif sequences within the ARID1A-occupied genomic regions from
ARID1A ChIP-seq (Fig. 7a). TBXT (T), repressor element-1 silencing transcription/
neuron-restrictive silencer factor (REST/NRSF), and MEF2C were the top three pre-
dicted co-TFs (Fig. 7b). REST/NRSF was known to specifically repress neural gene tran-
scription [38]. We then reanalyzed the published REST/NRSF ChIP-seq data
(ENCODE: ENCSR663WAR) generated in H1 hESCs. A notable overlap was observed
between REST- and ARID1A-occupied genes (Fig. 7c). There were total 1113 genes co-
occupied by ARID1A and REST (p = 9.3E−27). 28.0% (312 out of 1113) of the co-
occupied genes were neural (p = 2.1E−57) (Fig. 7d), and 4.2% (47 out of 1113) were car-
diac (p = 0.06) (Fig. 7e), indicating a strong bias that ARID1A and REST tend to co-
occupy more neural genes than cardiac genes. The lists of neural and cardiac genes
were from an unbiased database, the Human Protein Atlas database (https://www.pro-
teinatlas.org/). Next, integrated data analyses were performed on 40 essential neuro-
genic (Fig. 7f) and cardiogenic genes (Fig. 7g) showing descending differential
chromatin accessibility (DCA). The purple (1st column) and green (2nd column) bars
represented whether the gene was occupied by ARID1A and REST, respectively. The
3rd column in Fig. 7f, g indicated signal differences of DCA during cardiac commit-
ment. The two columns on the right (4th and 5th column) showed relative gene ex-
pressions in WT and ARID1A−/− hESC-derived cells post-cardiac differentiation. In
agreement with the results shown in Figs. 7d, e, REST and ARID1A co-occupied more
neurogenic genes (Fig. 7f) than cardiogenic genes (Fig. 7g). REST and ARID1A co-
occupied neural genes which showed various changes of chromatin accessibility, includ-
ing increased, decreased, or non-changed accessibility (Fig. 7f, DCA). However, expres-
sion levels of all these neurogenic genes increased in the middle of (Fig. 5f, j) and after
differentiation of ARID1A−/− cells when compared with WT cells (Fig. 7f, 4th and 5th
column). These results suggest that ARID1A-REST/NRSF interaction represses tran-
scription of co-occupied neurogenic genes. In contrast, REST barely co-occupied with
ARID1A on promoter regions of essential cardiogenic genes in Fig. 7g.
Interactions of ARID1A with REST, T, and MEF2C were confirmed using co-
immunoprecipitation (Co-IP) assay. Western blotting was performed to detect temporal
protein levels of REST, T, and MEF2C during cardiac differentiation of WT hESCs
(Fig. 7h). REST was expressed at all time points, with gradual decrease in levels as differ-
entiation progressed. T showed peak expression at day 2 (T2) of mesoderm formation.
MEF2C, a key cardiac TF, was expressed from day 6 (T6). REST was present in ARID1A
immune complex generated from hESCs (Fig. 7i). Moreover, anti-ARID1A antibody could
pull down T at day 2 (Fig. 7j) and MEF2C at day 6 (Fig. 7k) of cardiac differentiation, and
vice versa (Additional file 1: Figs. S7d-e), suggesting that ARID1A could subsequently
interact with T and MEF2C to regulate chromatin accessibility during human heart devel-
opment. Taken together, our results reveal the molecular mechanisms by which ARID1A
regulates early human cardiac and neural development from hESCs (Fig. 7l).
Discussion
In this study, we found ARID1A promoted human cardiac commitment via increasing
chromatin accessibility of essential cardiogenic genes and suppressed neural
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Fig. 7 ARID1A interacts with co-factors. a Prediction of co-factors interacting with ARID1A according to transcriptional
factor binding motifs in ARID1A ChIP-seq peaks. b Top three transcription factor motifs surrounding ARID1A cis-
regulatory binding elements. c Comparison between ARID1A-and REST-occupied gene lists from ChIP-seq datasets.
Hypergeometric model was used to calculate the significance of overlap between ARID1A and REST target genes, and
p value of enrichment of genes in both ARID1A and REST targets. d, e Comparison between ARID1A- and REST-
occupied neural (d) and cardiac genes (e) from ChIP-seq datasets, indicating that REST and ARID1A prefer to co-
occupy neural genes than cardiac genes. f Integrative analysis of ARID1A ChIP-seq (1st column), REST ChIP-seq (2nd
column), differential chromatin accessibility (DCA) by ATAC-seq (KO vs. WT) (3rd column), and average gene
expression levels (GE, log2 (fold change)) from scRNA-seq (KO vs. WT, 4th and 5th columns). Purple boxes (1st
column) show the representative ARID1A-occupied genes from d, while green boxes (2nd column) show REST
occupancies on those genes. g Same scheme design as f to show ARID1A and REST occupancies on representative
cardiogenic genes are shown. hWestern blotting to detect temporal protein expressions of REST, T, and MEF2C
during cardiac differentiation of hESCs. Protein samples were collected on days 0 (T0), 2 (T2), 3 (T3), 4 (T4), and 6 (T6).
i–k Co-IP validation of the interaction between ARID1A and REST in undifferentiated hESCs (T0) (i), the interaction
between ARID1A and T in hESCs at day 2 of differentiation (T2) (j), and the interaction between ARID1A and MEF2C in
hESCs at day 6 of differentiation (T6) (k). l Schematic summary of ARID1A’s roles in human cardiac and neural
commitment from hESCs
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commitment via repressing transcription of neurogenic genes. Thus, ARID1A is able to
coordinate human cardiogenesis and neurogenesis from pluripotent stem cells via dis-
tinct molecular mechanisms.
The classical function of SWI/SNF complex is to remodel chromatin state and DNA
accessibility to transcription factors and hence is critical for transcriptional regulation
and gene expression. Arid1a (Baf250a) has been previously reported to play important
role in mouse heart formation. Loss-of-Arid1a resulted in embryonic lethality with lack
of primitive streak or mesoderm formation [15, 17]. Arid1a ablation in mouse second
heart field (SHF) leads to trabeculation defects in the right ventricle [39]. Although pre-
vious in vivo studies revealed a critical role of Arid1a in mouse heart morphogenesis,
how ARID1A drives early stage human cardiogenesis from pluripotent stem cells re-
mains elusive. Our data demonstrate that ARID1A promotes human cardiac develop-
ment from hESCs by globally increasing chromatin accessibility on essential
cardiogenic genes, which include key mesoderm formation genes, cardiac specific tran-
scriptional factors, and sarcomeric genes. During cardiogenesis, temporal interaction of
ARID1A was observed with the genes encoding T (a key regulator of mesoderm forma-
tion) and MEF2C (a key cardiac cardiomyogenic transcriptional factor). These interac-
tions could very likely facilitate the sequential deposition of SWI/SNF complex on the
genes, thereby favoring cardiomyogenic differentiation. Although additional studies are
warranted, our data clearly indicate that early human cardiac fate commitment from
hESCs is largely dependent on the chromatin-remodeling role of SWI/SNF complex.
SWI/SNF complex was also found to regulate neurodevelopment in mouse. Mice
with loss of Brg [40], Baf47 (also known as Smarcb1) [41], or Baf155 (also known
as Smarcc1) [42] die at the pre- or peri-implantation stage. Conditional deletion of
Brg1 (an ATPase of SWI/SNF complex) in the developing mouse nervous system
results in the formation of a smaller brain that lacks a cerebellum [43]. These neu-
rodevelopmental defects could be due to failure of neural progenitor self-renewal
and/or differentiation [43, 44]. However, in contrast to the role of Brg1 in mouse
neural development, our data show that loss-of-ARID1A prominently enhanced
neurogenesis from hESCs. Knockout-of-ARID1A in hESCs increased neural differ-
entiation under both targeted cardiac and neural differentiation conditions. Since
the cardiac differentiation protocol was specifically modified to support mesoderm
and cardiomyocyte differentiation, the robust generation of neural cells from
ARID1A−/− hESCs under those conditions strongly suggests a master regulatory
role of ARID1A in governing neurogenesis. The increased neural differentiation of
ARID1A−/− hESCs and underdeveloped brain in Brg1 KO mice indicate that
ARID1A might have SWI/SNF-independent functions in neurogenesis. This was
proved by our finding that ARID1A did not uniformly affect the chromatin accessi-
bility on neurogenic genes, but rather globally controlled the transcriptional activity
of neurogenic genes. We found loss-of-ARID1A induced sporadic neural differenti-
ation together with increased expression of multiple neurogenic genes in hESCs.
Given the heterogeneity of hESCs, this observation suggests that the chromatin ac-
cessibility of neurogenic genes in subpopulations of undifferentiated hESCs is very
likely in a relatively open configuration. Thus, loss-of-ARID1A (and consequently
the ability to differentially remodel chromatin structure) would favor default tran-
scriptional activation of those genes. In fact, multiple previous studies reported that
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neural-associated genes in hESCs are under a bivalent condition with enhanced
chromatin and transcriptional plasticity, and tend to be transcribed [45–47].
It has previously been shown in mice that disruption of Arid1a-DNA interaction by a
single nucleotide variant (Arid1aV1068G/V1068G) [15] resulted in neural tube defects in-
cluding open head folds, neural tube closure defects, and heart defects such as trabecu-
lation defects, hypoplastic myocardial walls, and ventricular septal defects. Although it
was not defined whether the neural tube closure defects in Arid1aV1068G/V1068G mouse
were due to increased neurogenesis, it was previously reported that an increased num-
ber of neural stem cells will lead to defective neural tube closure [48–50]. Our ATAC-
seq and ChIP-seq in hESCs revealed that loss-of-ARID1A globally reduced chromatin
accessibility on promoters of cardiogenic genes and activated transcription of neuro-
genic genes. Taken together, the results from Arid1aV1068G/V1068G mouse model and
the ARID1A−/− hESCs data presented here demonstrate that ARID1A plays a conserved
and critical role in controlling both cardiogenesis and neurogenesis.
Our data show that ARID1A interacts with REST/NRSF. During embryogenesis,
REST/NRSF is widely expressed and plays a critical role in neuronal development. In
pluripotent stem cells and neural progenitors, REST represses a large pool of neuron-
specific genes essential for synaptic plasticity and remodeling, including synaptic vesicle
proteins, neuroreceptors, and ion channels [51–53]. The mechanism by which
ARID1A-REST recognizes target neurogenic genes remains elusive. A previous report
in HEK293 cells found that BRG1 enhanced REST-mediated repression of some target
genes by increasing the binding of REST with local chromatin [54]. Whether this was
mediated via REST-ARID1A interaction was not clear. Additionally, Pax6 (a master
neuroregulatory gene) interacts with neural progenitor BAF (npBAF) complex to regu-
late neurogenesis [55]. Therefore, it is likely that Pax6 (or other TFs) could guide
ARID1A-REST to target neurogenic genes during differentiation of hESCs. The obser-
vation that ChIP-seq revealed ARID1A occupancy on essential cardiogenic and neuro-
genic genes in undifferentiated hESCs suggests that cardiogenesis and neurogenesis
may be pre-determined by epigenetic machineries at the pluripotent stem cell stage.
This also suggests that ARID1A-SWI/SNF could associate with factor(s), other than
REST, to repress spontaneous cardiac differentiation in hESCs.
Conclusion
This study uncovers the essential and opposite roles of ARID1A in governing cardio-
genesis and neurogenesis from human pluripotent stem cells. Our findings reveal the
distinct mechanisms by which ARID1A globally enhances chromatin remodeling on
cardiogenic genes and suppresses transcription of neurogenic genes.
Methods
Human embryonic stem cell culture, cardiac differentiation, and neural differentiation
Human embryonic stem cell (hESC) line H9 was cultured on Matrigel (BD Biosci-
ences)-coated plates in mTesR medium [56, 57]. For cardiac differentiation, a mono-
layer differentiation method was used as described and reported [30]. Briefly, hESCs
were induced with chemically defined medium (CDM3, containing RPMI/1640, AA,
and BSA) as the basal medium [30] containing 6 μM CHIR99021 (Tocris Bioscience)
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from day 0 to day 2 and 5 μM XAV-939 (Tocris Bioscience) from day 2 to day 4, then
maintained in CDM3 basal medium without any chemicals for total 10–13 days. Beat-
ing cardiomyocytes were observed after differentiation for 8 to13 days. For neural dif-
ferentiation, H9 hESCs were dissociated and replated into 6-well plate (coated with
metrigel) and induced in N2B27 medium (25 mL DMEM/F12 medium, 1× N2, 25 mL
neurobasal medium, 1× B27, 1× Glutamax, 1× NEAA, and 1× penicillin-streptomycin).
After 4 days differentiation, cells were collected for experiments.
Vector cloning
Specific shRNA1 and shRNA2 targeting human ARID1A were cloned into the pLKO.1-
TRC-puro vector (Addgene), separately. shRNA scramble, as a negative control without
targeting any human genes, was also cloned into pLKO.1-TRC-puro vector.
CRISPR/Cas-9 mediated DNA manipulation
All gRNAs were designed based on CRISPR design platform from MIT (http://crispr.
mit.edu/). Full length of human ARID1A gene was knocked out by dual gRNAs in
hESC H9. For each gRNA oligo, self-complementary oligos were purchased from Invi-
trogen. Both of gRNAs, targeting 5′ sequence and 3′ sequence of ARID1A DNA, were
cloned into the pENTR-spCAS9-T2A-EGFP vector (from Dr. Yi Sheng), separately. Sin-
gle gRNA, targeting and disrupting ARID1A TSS, was cloned into the lentiCRISPRv2-
puro vector (Addgene) [58]. pENTR-spCAS9-T2A-EGFP-gRNA vectors were trans-
fected into H9 hESCs using X-treme GENE 9 DNA Transfection Reagent (Roche).
After 24 h transfection, GFP positive cells were sorted by FACSAria II cell sorter (BD
Biosciences) and replated to grow single clones in mTesR medium with ROCK inhibi-
tor Y-27632 (Tocris Bioscience). Single H9 clones were picked out and replated into
48-well plate for further expansion. Genomic DNAs of single H9 clones were extracted
by the DNeasy Blood & Tissue kit (Qiagen) kit. Null ARID1A hESC clones were veri-
fied by PCR using different primer sets. For ARID1A TSS disruption, H9 cells were in-
fected with lentiCRISPRv2-puro-ARID1A gRNA virus and puromycin was added to
select drug-resistant clones. LentiCRISPRv2-puro-ARID1A gRNA vector-mediated gen-
omic DNA editing on human ARID1A promoter was detected by Surveyor® Mutation
Detection Kit for Standard Gel Electrophoresis (Integrated DNA Technologies, Inc.).
Surveyor assay
Genomic DNA editing was detected using Surveyor® Mutation Detection Kit for Stand-
ard Gel Electrophoresis (Integrated DNA Technologies) according to manufacturer’s
instructions. Briefly, genomic DNA was extracted by DNeasy Blood & Tissue Kit (Qia-
gen). PCR fragments were purified by GeneJET PCR Purification Kit (K0701). After
that, PCR fragments were annealing in 1× prime star buffer (Takara) and Surveyor en-
zyme was added to digest the annealed DNA fragments at 42 °C for 1 h. Gel Electro-
phoresis on agarose gel was used to detect the digestion.
Lentivirus package and transduction
The lentiviral vector lentiCRISPRv2-puro was transfected into the HEK293T cells
(ATCC) along with packaging plasmids including psPAX2 and pMD2.G (from Dr.
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Guang Hu in NIH) using the X-treme GENE 9 transfection reagent (Roche). Viral
supernatant was collected, and cellular debris was removed by syringe filtering
(0.45 μm pore size; Millipore). Human H9 cells cultured in mTesR medium were incu-
bated with virus media for 4 h, followed with fresh mTesR medium culture for over-
night. The same infection was repeated after 24 h. Puromycin was added to select
puromycin-resistant H9 clones after virus infection for 48 h.
PCR screening of ARID1A−/− clones
hESC clones were picked and expanded in mTesR medium. Genomic DNAs from each
hESCs clone were purified by DNeasy Blood & Tissue Kits (Qiagen). PCRs with differ-
ent primer sets were conducted by using DreamTaq Green PCR Master Mix (Thermo
Scientific) or PrimeSTAR DNA Polymerase kit (Takara). PCR products were run on
agarose gel to visualize the fragment size. For all primers, please see Additional file 6:
Table S4.
RNA extraction and RT-quantitative PCR
Total RNAs were extracted by miRNeasy mini kit (Qiagen) or RNeasy Mini Kit (Qia-
gen). High-Capacity RNA-to-cDNA™ Kit (Applied Biosystems) was used for cDNA syn-
thesis. RT-quantitative PCR (RT-qPCR) was performed on a 7900HT Fast Real-Time
PCR System (Applied Biosystems) with Fast SYBR Green Master Mix (Applied Biosys-
tems). The RT-qPCR results were normalized to internal control GAPDH or beta-
ACTIN using the 2−ΔΔCt method as previously described [59]. RT-qPCR data were pre-
sented as mean ± SD from at least three independent experiments.
Western blotting
Cells were lysed, and proteins were purified by Complete™ Lysis-M EDTA-free kit
(Roche, 04719964001). Protein samples were run on Mini-PROTEAN® TGX™ Precast
Gels (Bio-Rad) and transferred to PVDF membranes by a wet transfer apparatus (Bio-
Rad). After blotting with 5% non-fat milk for 30 min at room temperature, the mem-
branes were incubated in TBXT buffer containing 5% non-fat milk and primary anti-
bodies at 4 °C overnight. On the next day, membranes were incubated in TBXT buffer
containing 5% non-fat milk and horseradish peroxidase (HRP)-conjugated anti-rabbit
or anti-mouse IgG (Cell Signaling Tech.) and detected by using ECL Western Blotting
Substrate (Pierce).
Co-immunoprecipitation (Co-IP)
Cell proteins were extracted by Pierce™ Classic Magnetic IP/Co-IP Kit (Thermo Scientific,
88804) or Complete™ Lysis-M EDTA-free kit (Roche, 04719964001) according to the
manuals. Protein co-immunoprecipitation (Co-IP) was performed by using Pierce™ Classic
Magnetic IP/Co-IP Kit as well. Protein samples were run on Mini-PROTEAN TGX Pre-
cast Gels (Bio-Rad) and probed with appropriate antibodies by Western blotting.
Chromatin immunoprecipitation-qPCR (ChIP-qPCR)
H9 hESCs were cultured in P10 plate in mTesRm medium. ChIP was carried out in un-
differentiated hESCs according to manuals of truChIP™ Chromatin Shearing Kit
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(Covaris, PN 520154) and EZ-Magna ChIP™ A/G Chromatin Immunoprecipitation Kit
(Millipore, 17-10086). Briefly, hESCs were fixed with methanol-free formaldehyde pro-
vided by truChIP™ Chromatin Shearing Kit (Covaris, PN 520154). Sonication of cell
lysis was done by a ME220 Focused-ultrasonicator using truChIP Chromatin Shearing
Tissue Kit (Covaris). Chromatin immunoprecipitation (ChIP) was performed by EZ
Magna ChIP™ A/G Chromatin Immunoprecipitation Kit (Millipore). Human ARID1A
antibody (Millipore: (04-080) Anti-BAF250a/ARID1a Antibody, clone PSG3) was used
to pull down genomic DNAs. Normal mouse/rabbit IgG or RNA Polymerase II anti-
bodies (provided by Millipore ChIP kit) were used as negative or positive control, re-
spectively. ChIP-qPCR signals were calculated as fold enrichment of 1% input or non-
specific antibody (isotype IgG antibodies) signals with at less three technical triplicates.
Each specific antibody ChIP sample was normalized to its isotype IgG antibody-ChIP
signals obtained in the same sample. Standard deviations (SD) were calculated from
technical triplicates and represented as error bars.
ChIP-sequencing (ChIP-seq)
H9 hESCs were cultured in P10 plate in mTesRm medium. ChIP was carried out in un-
differentiated hESCs according to the manuals of truChIP™ Chromatin Shearing Kit
(Covaris, PN 520154) and EZ-Magna ChIP™ A/G Chromatin Immunoprecipitation Kit
(Millipore, 17-10086). Briefly, hESCs were fixed with methanol-free formaldehyde pro-
vided by truChIP™ Chromatin Shearing Kit (Covaris, PN 520154). Chromatin of cell
lysis was sheared using truChIP™ Chromatin Shearing Kit according its manual by
ME220 Focused-ultrasonicator (Covaris). The sheared chromatin was then incubated
with anti-ARID1A antibody and purified by using EZ-Magna ChIP™ A/G Chromatin
Immunoprecipitation Kit (Millipore, 17-10086). Chromatin DNA quality was assessed
by 2100 Bioanalyzer (Agilent Technologies) and sequenced in the Center for Medical
Genomics at Indiana University School of Medicine.
Single-cell 3′ RNA sequencing (scRNA-seq)
H9 hESCs and differentiated hESCs were dissociated by Corning™ 0.25% Trypsin
(Corning™ 25053CI) to single cells. Single-cell 3′ RNA-seq experiments were conducted
using the Chromium single cell system (10X Genomics, Inc) and Illumina sequencers
at the Center of Molecular Genetics (CMG) of Indiana University School of Medicine.
Cell suspension was first inspected on the Countess II FL (Thermo Fisher Scientific)
and under microscope for cell number, cell viability, and cell size. Depending on the
quality of the initial cell suspension, the single-cell preparation included centrifugation,
resuspension, and filtration to remove cell debris, dead cells, and cell aggregates.
Single-cell capture and library preparation were carried out according to the Chromium
Single Cell 3′ Reagent kits V2 User Guide (10X Genomics PN-120267, PN-1000009,
PN-120262). Appropriate numbers of cells were loaded on a multiple-channel micro-
fluidics chip of the Chromium Single Cell Instrument (10X Genomics) with a targeted
cell recovery of 10,000. Single-cell gel beads in emulsion containing barcoded oligonu-
cleotides and reverse transcriptase reagents were generated with the v2 single cell re-
agent kit (10X Genomics). Following cell capture and cell lysis, cDNA was synthesized
and amplified. Illumina sequencing libraries were then prepared with the amplified
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cDNA. The resulting libraries were assessed with an Agilent TapeStation or Bioanalyzer
2100. The final libraries of the undifferentiated samples were sequenced using a custom
program on Illumina NextSeq 500/550, and the libraries of the differentiated samples
were sequenced on Illumina NovaSeq 6000. Twenty six base pairs of cell barcode and
UMI sequences, and 91 or 98 bp RNA reads were generated with Illumina NextSeq500/
550 or NovaSeq 6000.
Analysis of scRNA-seq data
CellRanger 2.1.0 (http://support.10xgenomics.com/) was utilized to process the raw se-
quence data generated. Briefly, CellRanger used bcl2fastq (https://support.illumina.
com/) to demultiplex raw base sequence calls generated from the sequencer into
sample-specific FASTQ files. The FASTQ files were then aligned to the human refer-
ence genome GRCh38 with RNA-seq aligner STAR. The aligned reads were traced
back to individual cells, and the gene expression level of individual genes was quantified
based on the number of UMIs (unique molecular indices) detected in each cell. The fil-
tered gene-cell barcode matrices generated with CellRanger were used for further ana-
lysis with the R package Seurat (version 2.3.1) [28] with Rstudio version 1.1.453 and R
version 3.5.1. Quality control (QC) of the data was implemented as the first step in our
analysis. We first filtered out genes that were detected in less than five cells and cells
with less than 200 genes. To further exclude low-quality cells in downstream analysis,
we used the function isOutlier from R package scater [29] together with visual inspec-
tion of the distributions of number of genes, UMIs, and mitochondrial gene content.
Cells with extremely high or low number of detected genes/UMIs were excluded. In
addition, cells with high percentage of mitochondrial reads were also filtered out. After
removing likely multiplets and low-quality cells, the gene expression levels for each cell
were normalized with the NormalizeData function in Seurat. To reduce variations
sourced from different numbers of UMIs and mitochondrial gene expression, we used
the ScaleData function to linearly regress out these variations. Highly variable genes
were identified (x.low.cutoff = 0.0125, x.high.cutoff = 4, y.cutoff = 0.5).
To integrate the single-cell data from undifferentiated or differentiated WT and
ARID1A−/− samples, we applied the canonical correlation analysis (CCA) in Seurat. We
chose the top 1500 variable genes from each sample to calculate the correlation compo-
nents (CCs) and used the function MetageneBicorPlot to determine the optimal number of
CCs. We retained the cells whose expression profiles could be explained with at least 50%
by the CCs using CalcVarExpRatio and SubsetData. The CCA subspaces were then aligned
with AlighSubspace using the number of CCs determined. We employed FindClusters for
shared nearest neighbor (SNN) graph-based clustering. The clusters were visualized with t-
distributed stochastic neighbor embedding (t-SNE) by running dimensionality reduction
with RunTSNE and TSNEPlot. The FindConservedMarkers function was subsequently used
to identify canonical cell type marker genes that are conserved across WT and knockout
cells. To compare average gene expression within the same cluster between WT and knock-
out cells, we applied AverageExpression. R packages ggplot2 (ISBN 978-3-319-24,277-4)
and ggrepel (https://github.com/slowkow/ggrepel) were used to plot the average gene ex-
pression. Violin plots (VlnPlot) and feature plots (FeaturePlot) were used to visualize spe-
cific gene expressions across clusters and different sample conditions.
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Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-
seq)
WT and ARID1A−/− hESCs were differentiated for 4 days; then, cells were dissociated
by Trypsin-EDTA (0.25%). Cells were washed by 1× PBS and resuspended in cold PBS
according to ATAC-seq protocol [60]. Briefly, collected cells were lysed in cold lysis
buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, and 0.1% IGEPAL CA-
630) and the nuclei were pelleted and resuspended in Tn5 enzyme and transposase buf-
fer (Illumina Nextera® DNA library preparation kit, cat# FC-121-1030). The Nextera li-
braries were amplified using the Nextera® PCR master mix and KAPA biosystems HiFi
hotstart readymix (cat # NC0295239) successively. AMPure XP beads (Beckman
Coulter cat# A63881) were used to purify the transposed DNA and the amplified PCR
products. All libraries were sequenced on a 100-cycle paired-end run on an Illumina
NOVAseq instrument. The resulting ATAC-seq libraries were sequenced on Illumina
NovaSeq 6000 at CMG of Indiana University School of Medicine, and paired-end 50 bp
reads were generated. Illumina adapter sequences and low-quality base calls were
trimmed off the paired-end reads with Trim Galore v0.4.3 (http://www.bioinformatics.
babraham.ac.uk/projects/trim_galore/). The resulting high-quality reads were aligned to
the human reference genome hg38 using bowtie2 (version 2.3.2) [61] with parameters
“-X 2000 --no-mixed --no-discordant.” Duplicate reads were discarded with Picard
(https://broadinstitute.github.io/picard/). Reads mapped to mitochondrial DNA to-
gether with low mapping quality reads (MAPQ < 10) were excluded from further ana-
lysis. ATAC-seq was conducted in Genomic Core at Indiana University.
Integrated analysis of ATAC-seq and ChIP-seq results
Bowtie2 [61] was used to align sequencing reads on the human genome (hg38) for both
ChIP-seq and ATAC-seq. Low-quality score (Q30) reads and redundant reads due to
PCR bias were filtered by SAMtools [62, 63] and Picard MarkDuplicates that were not
considered for further analysis. There were two technical replicates for ATAC-seq for
both WT and ARID1A−/−. Open chromatin regions for each sample were identified
first from peak calling of individual ATAC-seq using MACS2 [64] with broad peak op-
tion and cutoff of q < 0.1. We then constructed a final set of unique regions for differ-
ential analysis by merging overlapped open chromatin regions recognized from
different samples/conditions. The read abundance of each open region was counted for
each individual sample, respectively, by using pyDNase [65]. A software, edgeR [66, 67],
was employed to perform differential accessibility analysis on the read counts of each
chromatin region for WT and ARID1A−/− samples. Differentially accessible open chro-
matin regions between WT and ARID1A−/− were determined by specific cutoffs, FDR-
adjusted p value less than 0.01, and amplitude of fold change (in log scale with base 2)
larger than 0.5.
ARID1A binding sites were determined by model-based ChIP-seq data analysis using
MACS2 [64]. Peak calling of uniquely mapped ARID1A ChIP-seq reads was performed
by comparing with input ChIP-seq. All binding peaks were recognized if their p values
were less than 0.01 after the Benjamini-Hochberg multiple-test correction. We exam-
ined consensus sequences significantly enriched in ARID1A binding peaks. The motif
enrichment analysis was performed by using the HOMER (version 4.9.1) [68] command
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“findMotifsGenome.pl” with the parameter “-size given.” The open chromatin regions
detected by ATAC-seq or ARID1A binding sites identified by ARD1A ChIP-seq were
linked to specific genes, if they locate either within upstream 10 kb from TSS, or 5′
UTR, or exon/intron (gene body) of the genes. The UCSC genome browser custom
track was made to visualize differences of chromatin accessibility between WT and
ARID1A−/− for selected regions. The read numbers were normalized by total numbers
of high-quality reads in each sample, then multiplied by ten millions. The normalized
averaged counts for replicates under the same condition were presented in the figures.
Flow cytometry
Flow cytometry was performed according to our previous publication [69]. Briefly, cells
were harvested and dissociated by 0.25% Trypsin-EDTA for 5–10min at 37 °C. The dis-
sociated single cells were fixed in 4% PFA (diluted with 16% paraformaldehyde (formal-
dehyde) aqueous solution) for 10 min at room temperature and washed 3 times with
1× PBS. Cells were incubated in blocking PBS buffer containing 2% goat serum and
0.1% saponin. Then cells were incubated in blocking buffer with primary antibody for
1 h at 37 °C, following with secondary antibody staining for 1 h at 37 °C. Flow cytometry
analysis was carried out with Accuri C6 flow cytometer (Becton Dickinson), BD LSRII
cytometer (Becton Dickinson) and Attune NxT Flow Cytometer (Thermo Fisher Scien-
tific). Data were analyzed by FlowJo (Treestar).
Immunofluorescence (IF)
For immunocytochemistry, cells were fixed with 4% PFA (diluted from 16% Paraformal-
dehyde aqueous solution) for 10 min at room temperature. After washing with 1× PBS,
cells were blocked for 1 h with 1× PBS blocking buffer containing 2% goat serum (or
5% BSA) and 0.1% saponin. Staining with primary antibodies diluted with blocking buf-
fer was performed for overnight at − 4 °C. Staining with secondary antibodies was per-
formed on the next day, following with nucleus staining with DAPI. Leica DM6B image
system was used for imaging.
Functional enrichment analysis
The functional enrichment analysis, including Gene Ontology (GO), process networks,
signaling pathways, and gene interaction networks, was performed on gene sets selected
by using Metacore software (Clarivate Analytics). We chose the cutoff p < 0.05 to deter-
mine the functions significantly overrepresented in genes of our interest.
Quantification and statistical analysis
For RT-qPCR and flow cytometry data, comparisons between two groups (KO vs. WT)
were conducted using an unpaired two-tailed t test. All data were presented as mean ±
SD from at least three independent experiments. Differences with p values less than
0.05 were considered significant. A non-parametric test, Wilcoxon’s signed-rank test,
was used to compare the gene expression difference between WT and ARID1A−/− de-
tected by scRNA-seq. Fisher’s test was adopted to determine the statistical significance
of difference of ratios of cell numbers between WT and ARID1A−/−. We used hyper-
geometric model to calculate the significance of overlap between ARID1A and REST
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target genes, and p value of enrichment of cardiac or neural genes in both ARID1A and
REST targets.
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